BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26452158)

  • 1. NGF/TrkA Signaling as a Therapeutic Target for Pain.
    Hirose M; Kuroda Y; Murata E
    Pain Pract; 2016 Feb; 16(2):175-82. PubMed ID: 26452158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathway.
    Price EA; Krasowska-Zoladek A; Nanda KK; Stachel SJ; Henze DA
    J Neurosci Methods; 2017 Apr; 282():34-42. PubMed ID: 28279735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
    Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nerve growth factor in neuropathic pain inhibition produced by resiniferatoxin treatment in the dorsal root ganglia.
    Tender GC; Li YY; Cui JG
    Neurosurgery; 2013 Jul; 73(1):158-65; discussion 165-6. PubMed ID: 23615109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenesis and function of the NGF/TrkA signaling endosome.
    Marlin MC; Li G
    Int Rev Cell Mol Biol; 2015; 314():239-57. PubMed ID: 25619719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EXPRESS: NGF-trkA signaling modulates the analgesic effects of prostatic acid phosphatase in resiniferatoxin-induced neuropathy.
    Wu CH; Ho WY; Lee YC; Lin CL; Hsieh YL
    Mol Pain; 2016; 12():. PubMed ID: 27306411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1.
    Zhu W; Oxford GS
    Mol Cell Neurosci; 2007 Apr; 34(4):689-700. PubMed ID: 17324588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice.
    Rapp AE; Kroner J; Baur S; Schmid F; Walmsley A; Mottl H; Ignatius A
    J Orthop Res; 2015 Aug; 33(8):1235-41. PubMed ID: 25876530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auricular Vagal Nerve Stimulation Inhibited Central Nerve Growth Factor/Tropomyosin Receptor Kinase A/Phospholipase C-Gamma Signaling Pathway in Functional Dyspepsia Model Rats With Gastric Hypersensitivity.
    Zhou JZ; Chen H; Xu WL; Fu Z; Zhou S; Zhu WJ; Zhang ZH
    Neuromodulation; 2024 Feb; 27(2):273-283. PubMed ID: 36801128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local anesthetics suppress nerve growth factor-mediated neurite outgrowth by inhibition of tyrosine kinase activity of TrkA.
    Takatori M; Kuroda Y; Hirose M
    Anesth Analg; 2006 Feb; 102(2):462-7. PubMed ID: 16428543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.
    Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX
    World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting nerve growth factor in pain: what is the therapeutic potential?
    Watson JJ; Allen SJ; Dawbarn D
    BioDrugs; 2008; 22(6):349-59. PubMed ID: 18998753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor signaling in prostate health and disease.
    Arrighi N; Bodei S; Zani D; Simeone C; Cunico SC; Missale C; Spano P; Sigala S
    Growth Factors; 2010 Jun; 28(3):191-201. PubMed ID: 20166899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NGF-TrkA signaling in calcification of articular chondrocytes.
    Jiang Y; Tuan RS
    FASEB J; 2019 Sep; 33(9):10231-10239. PubMed ID: 31238006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Activation of TrkA Signaling.
    Duan L; Hope JM; Guo S; Ong Q; François A; Kaplan L; Scherrer G; Cui B
    ACS Synth Biol; 2018 Jul; 7(7):1685-1693. PubMed ID: 29975841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitated intracellular transport of TrkA by an interaction with nerve growth factor.
    Nomura M; Nagai T; Harada Y; Tani T
    Dev Neurobiol; 2011 Jul; 71(7):634-49. PubMed ID: 21312342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain.
    Ugolini G; Marinelli S; Covaceuszach S; Cattaneo A; Pavone F
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2985-90. PubMed ID: 17301229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensory Neuron-Specific Deletion of Tropomyosin Receptor Kinase A (
    O-Sullivan I; Kc R; Singh G; Das V; Ma K; Li X; Mwale F; Votta-Velis G; Bruce B; Natarajan Anbazhagan A; van Wijnen AJ; Im HJ
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
    Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.